E Mesdjian
Impact in
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
-
- Pharmacological Effects and Toxicity Studies
Papers in
-
- Pharmacological Effects and Toxicity Studies 20
-
- Epilepsy research and treatment 18
- Co-authors
- Charlotte Dravet (4 shared papers)Pierre Genton (7 shared papers)G Jadot (14 shared papers)J Roger (5 shared papers)M Valli (11 shared papers)Nicolas Giraud (1 shared paper)Renzo Guerrini (1 shared paper)Adriana Magaudda (1 shared paper)
- Journals
- Epilepsia (5 papers)Biopharmaceutics & Drug Disposition (3 papers)Life Sciences (3 papers)Epilepsy Research (2 papers)Therapeutic Drug Monitoring (1 paper)
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
E Mesdjian
34 papers receiving 435 citations
Peers
Comparison fields: 5 of 75
- Psychiatry and Mental health 202
- Pediatrics, Perinatology and Child Health 260
- Pharmacology 63
- Cellular and Molecular Neuroscience 90
- Oncology 84
Countries citing papers authored by E Mesdjian
This map shows the geographic impact of E Mesdjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Mesdjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Mesdjian more than expected).
Fields of papers citing papers by E Mesdjian
This network shows the impact of papers produced by E Mesdjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Mesdjian. The network helps show where E Mesdjian may publish in the future.
Co-authors
The 25 scholars most cited alongside E Mesdjian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. | 1992 | 87 |
| 2 | 1980 | 46 | |
| 3 | 1992 | 45 | |
| 4 | 1982 | 29 | |
| 5 | 1992 | 26 | |
| 6 | 1999 | 25 | |
| 7 | 1984 | 24 | |
| 8 | 1994 | 23 | |
| 9 | 1983 | 22 | |
| 10 | 1993 | 17 | |
| 11 | 1998 | 16 | |
| 12 | 1992 | 13 | |
| 13 | [Progressive myoclonus epilepsy with Lafora bodies. (Clinical, polygraphic and anatomic study of a case)]. | 1965 | 13 |
| 14 | 1993 | 11 | |
| 15 | 1993 | 8 | |
| 16 | 1985 | 7 | |
| 17 | 1968 | 7 | |
| 18 | 1996 | 6 | |
| 19 | 1986 | 4 | |
| 20 | 1965 | 4 |
About E Mesdjian
E Mesdjian is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Oncology and Physiology, having authored 35 papers that have together received 462 indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (20 papers), Epilepsy research and treatment (18 papers), Neuroscience and Neuropharmacology Research (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Metabolism and Genetic Disorders (5 papers), Pain Mechanisms and Treatments (4 papers), Anesthesia and Neurotoxicity Research (3 papers) and Diet and metabolism studies (3 papers). The work is most often cited by research in Psychiatry and Mental health (202 citations), Pediatrics, Perinatology and Child Health (260 citations), Pharmacology (63 citations), Cellular and Molecular Neuroscience (90 citations) and Oncology (84 citations). E Mesdjian has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include Charlotte Dravet, Pierre Genton, G Jadot, J Roger, M Valli, Nicolas Giraud, Renzo Guerrini, Adriana Magaudda, Grace A. Trentin and Souad R. Sennoune. Their work appears in journals such as Epilepsia, Biopharmaceutics & Drug Disposition, Life Sciences, Epilepsy Research and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.